Simergent
PrivateLast Round
Seed Round
Mar 27, 2026
Total Funding Raised
$13.73M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Simergent is a medical technology company that develops automated peritoneal dialysis devices for home use.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Health IoT
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Simergent Comparables
Compare Simergent with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Byonyks | 86% | |
| iRen-MEDICAL | 86% | |
| Triomed AB | 84% |
Simergent Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed Round | Mar 27, 2026 | ||||
| Series A | May 13, 2024 | ||||
| Series A | Mar 1, 2024 | ||||
| Grant | Jun 24, 2022 | ||||
| Grant | Dec 20, 2019 | ||||
Seed | Apr 18, 2019 |
Simergent Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| i2E | Seed |
| Plains Ventures | Series A |
| NIH RADx | Grant, Series A |
| Plains Ventures | Series A |
| SeedStep Angels | Seed |
| National Institute of Diabetes and Digestive and Kidney Diseases | Grant |
| Pathway Bioventures | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 18, 2026
Monthly visitors grew 311% MoM, from 382 to 1.6K.
- Mar 27, 2026
$9M round raised
Simergent Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Simergent's valuation, stock price, and market status.
Is Simergent a public or private company?
Simergent is a private company.
What is the current stock price of Simergent?
Simergent is a private company with no public stock price. No recent secondary market data is available.
How much is Simergent worth (valuation)?
Valuation information for Simergent is not publicly available.
Can I buy Simergent stock?
Simergent shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Simergent's last funding round?
Simergent's most recent funding round was Seed Round on March 27, 2026.
Who are the main investors in Simergent?
Key investors in Simergent include i2E, Plains Ventures, NIH RADx, National Institute of Diabetes and Digestive and Kidney Diseases, Pathway Bioventures.
Will Simergent IPO soon?
No public IPO plans have been announced for Simergent.
How can I track Simergent secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Simergent's secondary market activity and sign up for updates.